ETFs
Below are funds with Pyxis Oncology, Inc. stocks, sorted by market value. Equipped with price, change, and other helpful stats, they make investing in stocks more accessible and offer more opportunities at a lower risk.
Symbol | Market value | Weight | Issuer | Management style | Focus | Expense ratio | AUM | Price | Change % | Rel Volume | NAV total return 3Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
 IBBiShares Biotechnology ETF | 1.04 M USD | 0.02% | BlackRock, Inc. | Passive | Health care | 0.44% | 6.82 B USD | 157.72 USD | −0.45% | 1.04 | +22.85% |
| IWCiShares Micro-Cap ETF | 455.84 K USD | 0.05% | BlackRock, Inc. | Passive | Micro cap | 0.60% | 1 B USD | 149.27 USD | +0.58% | 1.82 | +44.12% |
| BTEEiShares NASDAQ US Biotechnology UCITS ETF | 146.85 K USD | 0.02% | BlackRock, Inc. | Passive | Health care | 0.35% | 47.46 M USD | 7.589 USD | −1.54% | 7.22 | +30.98% |
| BTECiShares NASDAQ US Biotechnology UCITS ETF | 146.85 K USD | 0.02% | BlackRock, Inc. | Passive | Health care | 0.35% | 705.52 M USD | 7.6175 USD | −1.46% | 1.10 | +30.98% |
 SBIOInvesco NASDAQ Biotech UCITS ETF | 88.12 K USD | 0.02% | Invesco Ltd. | Passive | Health care | 0.40% | 408.69 M USD | 54.42 USD | −1.59% | 0.59 | +29.97% |
 203780MIRAE ASSET TIGER NASDAQ BIO ETF | 10.7 K USD | 0.02% | Mirae Asset Global Investments Co., Ltd. | Passive | Health care | 0.30% | 50.32 M USD | 28,310 KRW | −0.16% | 0.80 | +36.03% |
| IBBQInvesco Nasdaq Biotechnology ETF | 9.45 K USD | 0.02% | Invesco Ltd. | Passive | Health care | 0.19% | 44.02 M USD | 26.39 USD | −0.48% | 1.49 | +32.22% |
 BIBProShares Ultra Nasdaq Biotechnology | 9.28 K USD | 0.01% | ProShare Advisors LLC | Passive | Health care | 0.95% | 68.85 M USD | 69.53 USD | −1.02% | 6.47 | +28.74% |